Originally, Vancomycin was considered a drug of last resort as penicillin was effective for most infections. Currently, clinicians typically prescribe Vancomycin for suspected or known staph infections or resistant bacteria where other options such as beta-lactams are not effective.

Unfortunately for patients who need Vancomycin, the size of it limits the effectiveness of oral administration. Because of this limitation and its complexity, Vancomycin requires close monitoring to ensure the therapeutic benefits of the drug while decreasing adverse effects. 

DoseMeRx® provides software that allows for close monitoring of the Vancomycin to manage the patient’s drug therapy. Clinicians and patients will receive peace of mind when transitioning to AUC-based dosing with the only HITRUST certified Bayesian dosing platform. Gone are the manual methods and complicated calculations that may not be correct.

This easy-to-use decision support software is used by more than 2,000 clinicians worldwide to optimize vancomycin dosing for thousands of patients. The platform leverages clinically validated pharmacokinetic drug models, patient characteristics, and drug concentrations to guide dose optimization of Vancomycin.